A mutant Shiga-like toxin IIe bound to its receptor Gb3: Structure of a group II Shiga-like toxin with altered binding specificity. Structure 8(3): 253-264, March 15, 2000
Shiga toxin binding correlates with P1 blood group antigen in human endothelial cells and erythrocytes. Abstracts of the General Meeting of the American Society for Microbiology 101: 93, 2001
Shiga toxin binding correlates with P1 blood group antigen in human adult and cord erythrocytes. Glycobiology 11(10): 903, 2001
Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. Journal of Infectious Diseases 201(7): 1081-1083, 2010
Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. Journal of Bacteriology 172(2): 653-658, 1990
Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Journal of Clinical Microbiology 27(6): 1145-1150, 1989
Quantitation and localization of shiga toxin/shiga-like toxin-binding glycolipid receptors in human and baboon tissues. Karmali, M A, Goglio, A G International Congress Series; Recent advances in verocytotoxin producing Escherichia coli infections 189-195, 1994
Inhibition of elongation factor 1 dependent aminoacyl transfer rna binding to ribosomes by shiga like toxin i vt1 from escherichia coli o157 h7 and by shiga toxin. FEMS Microbiology Letters 44(1): 91-94, 1987
The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagnostic Microbiology and Infectious Disease 59(3): 235-242, 2007
Influence of the culture parameters on growth and Shiga toxin expression of Shiga-toxin producing Escherichia coli (STEC). Zycie Weterynaryjne 82(9): 756-762, 2007
Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes. Infection and Immunity 57(9): 2811-2814, 1989
Combined use of demonstration of Shiga toxin in enrichment culture and enterohemolyin on washed sheep blood agar for the isolation of non-O157H7/- Shiga toxin-producing Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 101: 186, 2001
Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR. Journal of Medical Microbiology 58(Pt 7): 971-973, 2009
The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of. 2007
Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrology, Dialysis, Transplantation 22(3): 749-755, 2006